Comparison of models to predict clinical failure after radical prostatectomy (pages 303–310)
Scott E. Eggener, Andrew J. Vickers, Angel M. Serio, Michael J. Donovan, Faisal M. Khan, Valentina Bayer-Zubek, David Verbel, Carlos Cordon-Cardo, Victor E. Reuter, Fernando J. Bianco Jr and Peter T. Scardino
Version of Record online: 24 NOV 2008 | DOI: 10.1002/cncr.24016
Models are available to accurately predict biochemical disease recurrence (BCR) after radical prostatectomy. Because not all patients who experience BCR will progress to metastatic disease, it is appealing to determine postoperatively which patients are likely to manifest systemic disease. The authors compared the ability of postoperative models to predict metastatic disease following radical prostatectomy.